Open AccessSubgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
Author(s) -
Mine Esen Barış,
Jale Menteş,
Filiz Afrashi,
Serhad Nalçacı,
Cezmi Akkın
Publication year - 2020
Publication title -
türk oftalmoloji dergisi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 10
eISSN - 2147-2661
pISSN - 1300-0659
DOI - 10.4274/tjo.galenos.2020.38488
Subject(s) - macular degeneration , medicine , choroidal neovascularization , ranibizumab , occult , contraindication , incidence (geometry) , ophthalmology , prospective cohort study , neovascularization , surgery , angiogenesis , bevacizumab , chemotherapy , pathology , physics , alternative medicine , optics
This study aimed to determine the incidence of poor response to intravitreal (IV) anti-VEGF treatment in neovascular age-related macular degeneration (nvAMD) and to define subgroups of poor responders.